Introducing Russia's Honest Label System, CRPT

Nov.11.2022
Introducing Russia's Honest Label System, CRPT
Russia's CRPT is a government-operated product label and tracking system to combat illegal markets and regulate taxes.

The "Honest Label" CRPT is a system for electronic tagging and tracking of goods information launched by the government of the Russian Federation, officially in operation since 2019. The system uploads product data to the Federal Tax Service and Quality Supervision Department to assist in taxation and product quality regulation.


Tobacco products were among the first goods included in this system. Prior to the introduction of labels, the illegal tobacco market in Russia was rapidly expanding. However, since the implementation of labels, it has been steadily decreasing year by year. By 2022, the illegal market share had decreased by a quarter, falling from 15.6% in 2019 to 11.5% in 2021.


Honest Labels on Products/Image Source: YANDEX


According to the data from the Russian Ministry of Industry and Trade, the effectiveness of market control and product supervision enforcement has significantly improved due to "honest labeling." In the first quarter of 2022, the number of illegal tobacco products seized was 11.1 million packs, a 72.5% increase compared to a year ago. At the same time, the number of legally registered tobacco sales outlets increased by 29%.


Currently, the system has implemented the issuance of electronic tags for tobacco products, certain pharmaceutical products, shoes, clothing, cameras, tires, and perfumes. In the future, electronic tags will be extended to all production fields, from bicycles and household chemicals to pipelines and industrial cables, among other industries.


Starting on December 1st, 2022, all electronic cigarette products will be required to have "honest labeling" and products without proper labeling will be prohibited from being sold on the market.


Currently, the illegal distribution of electronic cigarettes is rampant in the Russian market, and the government regulatory agencies have been lacking effective means to regulate the market. The Ministry of Finance has repeatedly stated that it plans to increase the tax budget for electronic cigarette products by 2023, and tighter regulation is the trend.


The mandatory implementation of "honest labeling" will impact the illegal circulation market. Incomplete statistics indicate that less than half of the electronic cigarette products on the market have been labeled. The budget proposal for regulating electronic cigarettes in the Russian Duma Parliament shows that the legalization of the electronic cigarette market will increase government tax revenue by over 100 billion rubles. Building on their success in regulating the traditional tobacco market, the Russian federal government will continue to push for the mandatory inclusion of electronic cigarette products in "honest labeling.


2FIRSTS will continue to bring you related news on 'honest labeling'.


1) This article is solely intended for internal industry communication and discussion and does not serve as an endorsement or recommendation for any brand or product. 2) Smoking is harmful to one's health. Minors are prohibited from reading this article.


This article is an original creation of Shenzhen 2FIRSTS Technology Co., Ltd, and its copyright and permission to use belongs to the company. Any unauthorized reproduction, reprinting, or other infringement of the company's copyright by any individual or entity is strictly prohibited. The company reserves the right to take legal action against violators.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane’s 2026 update of its living review on electronic cigarettes for smoking cessation included 80 randomized controlled trials involving 29,861 adult smokers, with nine trials added in this update. The review retained its high-certainty conclusion that nicotine e-cigarettes increase smoking cessation rates compared with nicotine replacement therapy. In absolute terms, about 10 in 100 people using nicotine e-cigarettes may quit smoking for at least six months, compared with about 6 in 100 using NRT. The review found no clear difference in serious adverse event rates between the two groups, while longer-term safety and the relative effectiveness of newer device types remain less certain.
Sep.07
PMI Q2 Call: ZYN Growth, IQOS Pricing and a Diverging Global Tobacco Market
PMI Q2 Call: ZYN Growth, IQOS Pricing and a Diverging Global Tobacco Market
Philip Morris International’s second-quarter earnings call offered new detail on its smoke-free strategy. Management said it would increase U.S. investment behind nicotine pouch brand ZYN, keep IQOS focused on volume before stronger pricing, and use SENTIA, DELIA, LEVIA, VEEV and ZYN to manage tax and regulatory pressure across Japan and Europe. Analysts from Goldman Sachs, Morgan Stanley, UBS and other firms also pressed PMI on profitability, market share, cigarette resilience and the durability of its global transformation over coming quarters.
Jul.24
PMI Global Communications Chief Moira Gilchrist: Why AI Matters More Than Ever in the Smoke-Free Transition
PMI Global Communications Chief Moira Gilchrist: Why AI Matters More Than Ever in the Smoke-Free Transition
Philip Morris International (PMI) Chief Global Communications Officer Moira Gilchrist said artificial intelligence is changing how companies understand audiences, manage owned information channels and communicate business transformation. PMI is using AI-generated audience personas to test messaging while optimizing its corporate website and other owned channels for large language models. As PMI continues its transition from cigarettes toward smoke-free products, Gilchrist said owned data and corporate channels are becoming increasingly important in demonstrating the scale of that transformation.
Aug.26
After Apple Business Decline, South Korea’s ITM Semiconductor Expands KT&G Vape Supply Chain as Vape Revenue Rises 24.8%
After Apple Business Decline, South Korea’s ITM Semiconductor Expands KT&G Vape Supply Chain as Vape Revenue Rises 24.8%
South Korean electronics component supplier ITM Semiconductor is reshaping its business portfolio after a decline in Apple-related protection circuit business, expanding its supply of vape devices and cartridges to KT&G. According to News1 on August 18, 2026, ITM’s vape-related revenue rose 24.8% year on year to 75.5 billion won in the first half of 2026. The company began mass production of vape devices at its Cikarang, Indonesia facility in January 2026, strengthening export manufacturing capacity. Meanwhile, Samsung-related protection circuit sales continued to grow, providing support during the transition.
Aug.20
Product | SKE Launches FRESA PRO in the U.S., Introducing Fresh Lock Technology for E-Liquid Management in High-Capacity Vapes
Product | SKE Launches FRESA PRO in the U.S., Introducing Fresh Lock Technology for E-Liquid Management in High-Capacity Vapes
Shenzhen SKE Technology has launched the FRESA PRO in the United States, a high-capacity rechargeable disposable vape featuring Fresh Lock electromagnetic valve supply control technology. The device combines a claimed capacity of up to 40,000 puffs, dual mesh coils, dual output modes and a transparent tank design. The launch reflects the high-capacity disposable vape segment’s shift from puff-count competition toward improved e-liquid management and device-level experience.
Aug.03
FDA Grants PMTA Authorization to 11 ZYN ULTRA Nicotine Pouches, Bringing Total Authorized Pouches to 43
FDA Grants PMTA Authorization to 11 ZYN ULTRA Nicotine Pouches, Bringing Total Authorized Pouches to 43
The U.S. Food and Drug Administration authorized 11 ZYN ULTRA nicotine pouch products made by Swedish Match USA through the premarket tobacco product application pathway on August 21, 2026. Ten of the authorized products have a labeled nicotine content of 9 mg, while ZYN ULTRA Smooth was authorized at 11 mg. The reviews were conducted through FDA’s nicotine pouch PMTA pilot program. FDA has now authorized 43 nicotine pouch products, including 23 through the pilot.
Aug.24